Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.3900
+0.0052 (1.35%)
At close: Aug 13, 2025, 4:00 PM
0.3850
-0.0050 (-1.28%)
After-hours: Aug 13, 2025, 5:32 PM EDT
Athira Pharma Market Cap
Athira Pharma has a market cap or net worth of $15.38 million as of August 13, 2025. Its market cap has decreased by -87.88% in one year.
Market Cap
15.38M
Enterprise Value
-13.63M
1-Year Change
-87.88%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since the IPO on September 18, 2020, Athira Pharma's market cap has decreased from $489.85M to $15.38M, a decrease of -96.86%. That is a compound annual growth rate of -50.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 15.18M | -33.11% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | 1.11B | 127.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |